Annovis Bio

Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward

BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases, recently announced a significant milestone in its clinical trial journey. The …

Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward Read More

dementia, alzheimer disease

Pennsylvania Department of Aging Hosts 2023 ADRD Virtual Forum, Highlights Lewy Body and Frontotemporal Dementias

PENNSYLVANIA — On Thursday, the Pennsylvania Department of Aging held its annual Alzheimer’s Disease and Related Disorders (ADRD) Virtual Forum. The forum, which attracted over 400 attendees, serves to educate, …

Pennsylvania Department of Aging Hosts 2023 ADRD Virtual Forum, Highlights Lewy Body and Frontotemporal Dementias Read More